Drugs / In111-Pentetréotide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02465112 | Sep 2015 → Oct 2018 | digestive system neuroendocrine neoplasm | GERCOR - Multidisciplinary Oncology Cooperative Group | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | In111-Pentetréotide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02465112 ↗ |
| Modality | Other / unclassified | “targeted radionuclide therapy” NCT02465112 ↗ |